Patents by Inventor Venugopal Allavatam

Venugopal Allavatam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170156617
    Abstract: Methods and/or device facilitating and selecting among multiple modes of filtering a cardiac electrical signal, in which one filtering mode includes additional high pass filtering of low frequency signals, relative to the other filtering mode. The selection filtering modes may include comparing sensed signal amplitude to one or more thresholds, using the multiple modes of filtering. In another example, an additional high pass filter is enabled, over and above a default or baseline filtering mode, and the detected cardiac signal is monitored for indications of possible undersensing, and/or for drops in amplitude toward a threshold, and the additional high pass filter may be disabled upon finding of possible undersensing or drop in signal amplitude.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 8, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Venugopal Allavatam, Stephen J. Hahn, Keith L. Herrmann, Mitchell D. Lanz, Krzysztof Z. Siejko, Benjamin Speakman
  • Publication number: 20170156670
    Abstract: In some examples, cardiac cycle detection may be used as a more or less default approach to cardiac activity tracking. Additional rate measurement relying on different sources or analyses may require extra power consumption over the cycle detection methods. Therefore, new methods and devices are disclosed that selectively activate a second cardiac rate measurement when needed. In some illustrative methods and devices, decisions are made as to whether and which previously collected data, if any, is to be discarded, replaced, or corrected upon activation of the second cardiac rate measurement.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 8, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Krzysztof Z. Siejko, Amy Jean Brisben, Stephen J. Hahn, Keith L. Herrmann, Venugopal Allavatam
  • Publication number: 20170156669
    Abstract: In some examples, cardiac cycle detection may be used as an approach to cardiac activity tracking, with one or more second approaches to cardiac activity tracking also available for use. Additional rate measurement relying on different sources or analyses may require extra power consumption over the cycle detection methods. Therefore, new methods and devices are disclosed that selectively activate a second cardiac rate measurement. In some illustrative methods and devices, decisions are made as to whether and which previously collected data, if any, is to be discarded, replaced, or corrected upon activation of the second cardiac rate measurement. In some illustrative methods and devices, a cardiac cycle detection approach to cardiac activity tracking may be bypassed by a second cardiac rate measurement.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 8, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Krzysztof Z. Siejko, Venugopal Allavatam, Amy Jean Brisben, Stephen J. Hahn, Keith L. Herrmann
  • Patent number: 9668665
    Abstract: Methods and devices for accelerating the identification of arrhythmias in implantable medical devices. Following identification of a potential arrhythmia onset condition, such as by identifying a plurality of closely coupled detected events, a retrospective pattern recognition analysis is performed to seek out a possible onset comprising a Torsades de Pointes. Although the methods and devices are designed to target Torsades de Pointes, wider application to other arrhythmia onset conditions is contemplated as well.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: June 6, 2017
    Assignee: Cameron Health, Inc.
    Inventors: Mark R. Schroeder, Venugopal Allavatam
  • Patent number: 9636514
    Abstract: Methods and devices for adjusting therapy delivery decisions in an implantable cardiac stimulus device. Some example methods and devices use a first counter to track benign cardiac activity during therapy preparations and a second counter to track shockable cardiac activity once therapy is ready. Therapy can then be delivered if or when the second counter exceeds the first counter.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: May 2, 2017
    Assignee: Cameron Health, Inc.
    Inventors: Jay A. Warren, Rick Sanghera, Venugopal Allavatam
  • Publication number: 20170113050
    Abstract: Methods and devices for combining multiple signals from multiple sensing vectors for use in wearable or implantable cardiac devices. Signals from multiple vectors may be combined using weighting factors and/or by conversion to different coordinate systems than the original inputs, which may or may not be normalized to patient anatomy. Signals from multiple sensing vectors may be combined prior to or after several analytical steps or processes including before or after filtering, and before or after cardiac cycle detection. Cardiac cycle detection information may be combined across multiple sensing vectors before or after analysis of individual vectors for noise or overdetection. Cardiac cycle detection information may also be combined across multiple sensing vectors to identify noise and/or overdetection.
    Type: Application
    Filed: October 19, 2016
    Publication date: April 27, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Amy Jean Brisben, Venugopal Allavatam, Deepa Mahajan, Krzysztof Z. Siejko, Kevin G. Wika, Keith L. Herrmann, Stephen J. Hahn
  • Publication number: 20170112399
    Abstract: Methods and devices for combining multiple signals from multiple sensing vectors for use in wearable or implantable cardiac devices. A preferred sensing configuration may be selected at a given point in time, for example under clinical conditions. Signal quality for the preferred sensing configuration is then monitored, and if the signal quality degrades under selected conditions, re-analysis may be performed to select a different sensing vector configuration for at least temporary use. If signal quality increases for the preferred sensing configuration, temporary use of the different sensing vector configuration may cease and reversion to the preferred sensing configuration takes place if certain conditions are met. The conditions for reversion may depend in part of a history of sensing signal quality for the preferred sensing configuration.
    Type: Application
    Filed: October 19, 2016
    Publication date: April 27, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Amy Jean Brisben, Venugopal Allavatam, Krzysztof Z. Siejko, Deepa Mahajan, Kevin G. Wika, Keith L. Herrmann, Stephen J. Hahn
  • Publication number: 20170113040
    Abstract: Methods and devices for combining multiple signals from multiple sensing vectors for use in wearable or implantable cardiac devices. Signals from multiple vectors may be combined using weighting factors and/or by conversion to different coordinate systems than the original inputs, which may or may not be normalized to patient anatomy. Signals from multiple sensing vectors may be combined prior to or after several analytical steps or processes including before or after filtering, and before or after cardiac cycle detection. Cardiac cycle detection information may be combined across multiple sensing vectors before or after analysis of individual vectors for noise or overdetection. Cardiac cycle detection information may also be combined across multiple sensing vectors to identify noise and/or overdetection.
    Type: Application
    Filed: October 19, 2016
    Publication date: April 27, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Amy Jean Brisben, Venugopal Allavatam, Krzysztof Z. Siejko, Deepa Mahajan, Kevin G. Wika, Keith L. Herrmann, Stephen J. Hahn
  • Publication number: 20170113053
    Abstract: New and alternative approaches to the monitoring of cardiac signal quality for external and/or implantable cardiac devices. In one example, signal quality is monitored continuously or in response to a triggering event or condition and, upon identification of a reduction in signal quality, a device may reconfigure its sensing state. In another example, one or more trends of signal quality are monitored by a device, either continuously or in response to a triggering event or condition, and sensing reconfiguration may be performed in response to identified trends and events. In yet another example, a device may use a looping data capture mode to track sensing data in multiple vectors while primarily relying on less than all sensing vectors to make decisions and, in response to a triggering event or condition, the looped data can be analyzed automatically, without waiting for additional data capture to reconfigure sensing upon identification of the triggering event or condition.
    Type: Application
    Filed: October 19, 2016
    Publication date: April 27, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Amy Jean Brisben, Venugopal Allavatam, Krzysztof Z. Siejko, Deepa Mahajan, Kevin G. Wika, Keith L. Herrmann, Stephen J. Hahn
  • Publication number: 20170095175
    Abstract: Implantable medical device systems and methods configured to use a detection profile selected from among a plurality of detection profiles to define a detection threshold for identifying cardiac events, in which a close call definition is used to determine which of the plurality of detection profiles is to be chosen. Upon identifying a close call, in which an overdetection nearly occurred but did not actually take place, a relatively less sensitive detection profile is chosen.
    Type: Application
    Filed: December 19, 2016
    Publication date: April 6, 2017
    Applicant: CAMERON HEALTH, INC.
    Inventor: Venugopal Allavatam
  • Publication number: 20170056681
    Abstract: In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient. The sensed cardiac signal information is then amplified and filtered. Parameters such as rate, QRS pulse width, cardiac QRS slew rate, amplitude and stability measures of these parameters from the filtered cardiac signal information are measured, processed and integrated to determine if the cardioverter/defibrillator needs to initiate therapeutic action.
    Type: Application
    Filed: November 14, 2016
    Publication date: March 2, 2017
    Applicant: CAMERON HEALTH, INC.
    Inventors: Gust H. Bardy, William J. Rissmann, Alan H. Ostroff, Paul J. Erlinger, Venugopal Allavatam
  • Patent number: 9579065
    Abstract: Systems, methods and non-transient software media for performing sensing vector selection in an implantable cardiac device by assessing biphasic or monophasic characteristics of the cardiac signal in vectors under analysis. A factor associated with the biphasic or monophasic nature of the cardiac signal, as seen from a given sensing vector, can be inserted into the assessment of which of several available sensing vectors is considered “best” for purposes of cardiac signal analysis. Additional factors may be considered beyond the biphasic or monophasic nature including the quantity of turning points or inflections and amplitude variability.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: February 28, 2017
    Assignee: CAMERON HEALTH INC.
    Inventors: Venugopal Allavatam, Rick Sanghera, Mark R. Schroeder
  • Publication number: 20170050037
    Abstract: Methods and devices for cardiac therapy. One example provides a subcutaneous anti-tachycardia pacing therapy. Another example provides a subcutaneous low energy cardioversion therapy. Yet another example provides a subcutaneous multiple pulse cardioversion therapy. In various examples, specific steps are taken to ensure synchronization of delivered therapy when provided in response to sensing and analysis of a subcutaneous signal. Some examples use a substernal device instead.
    Type: Application
    Filed: August 9, 2016
    Publication date: February 23, 2017
    Applicant: CARDIAC PACEMAKERS, INC.
    Inventors: Stephen J. Hahn, Paul Freer, Venugopal Allavatam
  • Patent number: 9554714
    Abstract: Implantable medical device systems and methods configured to use a detection profile selected from among a plurality of detection profiles to define a detection threshold for identifying cardiac events, in which a close call definition is used to determine which of the plurality of detection profiles is to be chosen. Upon identifying a close call, in which an overdetection nearly occurred but did not actually take place, a relatively less sensitive detection profile is chosen.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: January 31, 2017
    Assignee: CAMERON HEALTH INC.
    Inventor: Venugopal Allavatam
  • Patent number: 9522283
    Abstract: In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient. The sensed cardiac signal information is then amplified and filtered. Parameters such as rate, QRS pulse width, cardiac QRS slew rate, amplitude and stability measures of these parameters from the filtered cardiac signal information are measured, processed and integrated to determine if the cardioverter/defibrillator needs to initiate therapeutic action.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: December 20, 2016
    Assignee: CAMERON HEALTH INC.
    Inventors: Gust H. Bardy, William J. Rissmann, Alan H. Ostroff, Paul J. Erlinger, Venugopal Allavatam
  • Publication number: 20160331985
    Abstract: Methods and devices providing multiple criteria for use in arrhythmia identification. Based on inputs including defined rules or parameters, one of a more conservative or more aggressive set of arrhythmia identification parameters can be selected. One or the other of the selectable sets of arrhythmia identification parameters may also be adaptive or modifiable during the use of the system, for example, in response to identified nonsustained episodes, the more conservative set of arrhythmia identification parameters can be modified to become still more conservative. Such modification of arrhythmia identification criteria allows reduced time to therapy when indicated, while allowing more deliberate decisions in other circumstances.
    Type: Application
    Filed: July 26, 2016
    Publication date: November 17, 2016
    Applicant: CAMERON HEALTH, INC.
    Inventors: Venugopal Allavatam, Rick Sanghera
  • Publication number: 20160270681
    Abstract: Methods and devices for sensing vector analysis in an implantable cardiac stimulus system. In an illustrative example, a first sensing vector is analyzed to determine whether it is suitable, within given threshold conditions, for use in cardiac event detection and analysis. If so, the first vector may be selected for detection and analysis. Otherwise, one or more additional vectors are analyzed. A detailed example illustrates methods for analyzing sensing vectors by the use of a scoring system. Devices adapted to perform these methods are also discussed, including implantable medical devices adapted to perform these methods, and systems comprising implantable medical to devices and programmers adapted to communicate with implantable medical devices, the systems also being adapted to perform these methods. Another example includes a programmer configured to perform these methods including certain steps of directing operation of an associated implanted or implantable medical device.
    Type: Application
    Filed: May 31, 2016
    Publication date: September 22, 2016
    Applicant: CAMERON HEALTH INC.
    Inventors: Rick Sanghera, Venugopal Allavatam
  • Publication number: 20160250488
    Abstract: Methods, implantable medical devices and systems configured to perform analysis of captured signals from implanted electrodes to identify cardiac arrhythmias. In an illustrative embodiment, signals captured from two or more sensing vectors are analyzed, where the signals are captured with a patient in at least first and second body positions. Analysis is performed to identify primary or default sensing vectors and/or templates for event detection.
    Type: Application
    Filed: May 10, 2016
    Publication date: September 1, 2016
    Applicant: CAMERON HEALTH INC.
    Inventors: Rick Sanghera, Venugopal Allavatam
  • Patent number: 9421390
    Abstract: Methods and devices providing multiple criteria for use in arrhythmia identification. Based on inputs including defined rules or parameters, one of a more conservative or more aggressive set of arrhythmia identification parameters can be selected. One or the other of the selectable sets of arrhythmia identification parameters may also be adaptive or modifiable during the use of the system, for example, in response to identified nonsustained episodes, the more conservative set of arrhythmia identification parameters can be modified to become still more conservative. Such modification of arrhythmia identification criteria allows reduced time to therapy when indicated, while allowing more deliberate decisions in other circumstances.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: August 23, 2016
    Assignee: CAMERON HEALTH INC.
    Inventors: Venugopal Allavatam, Rick Sanghera
  • Publication number: 20160236001
    Abstract: Methods, systems, and devices for signal analysis in an implanted cardiac monitoring and treatment device such as an implantable cardioverter defibrillator. In illustrative examples, captured data including detected events is analyzed to identify likely overdetection of cardiac events. In some illustrative examples, when overdetection is identified, data may be modified to correct for overdetection, to reduce the impact of overdetection, or to ignore overdetected data. New methods for organizing the use of morphology and rate analysis in an overall architecture for rhythm classification and cardiac signal analysis are also discussed.
    Type: Application
    Filed: April 26, 2016
    Publication date: August 18, 2016
    Applicant: CAMERON HEALTH INC.
    Inventors: Venugopal Allavatam, Surekha Palreddy, Rick Sanghera, Jay A. Warren